JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Surgery Partners
SGRY
$1.91B
| $8.6M | ﹤0.01% |
710,515
+185,740
| +35% | +$1.78M |
|
2152
Sally Beauty Holdings
SBH
$1.54B
| $8.6M | ﹤0.01% |
458,140
+65,071
| +17% | +$1.13M |
|
2153
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$425M
| $8.59M | ﹤0.01% |
338,962
+9,573
| +3% | +$236K |
|
|
CORR
2154
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $8.58M | ﹤0.01% |
224,492
+185,842
| +481% | +$6.74M |
|
|
BRFS
2155
DELISTED
BRF SA
BRFS
| $8.56M | ﹤0.01% |
760,562
-431,580
| -36% | -$5.51M |
|
|
SRCLP
2156
DELISTED
Stericycle, Inc
SRCLP
| $8.56M | ﹤0.01% |
161,666
+14,946
| +10% | +$811K |
|
2157
American Vanguard Corp
AVD
$65.5M
| $8.54M | ﹤0.01% |
434,834
+14,312
| +3% | +$296K |
|
|
HES
2158
PUT
DELISTED
Hess
HES
| $8.54M | ﹤0.01% |
180,000
-150,000
| -45% | -$6.77M |
|
|
BRS
2159
DELISTED
Bristow Group, Inc.
BRS
| $8.53M | ﹤0.01% |
632,930
+176,589
| +39% | +$2.09M |
|
|
DCH
2160
Dauch Corp
DCH
$1.63B
| $8.51M | ﹤0.01% |
499,811
+10,469
| +2% | +$185K |
|
|
GRP.U
2161
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $8.51M | ﹤0.01% |
225,411
+73,626
| +49% | +$2.91M |
|
|
RPAI
2162
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $8.51M | ﹤0.01% |
632,781
+498,390
| +371% | +$6.48M |
|
|
WCC
2163
WESCO International
WCC
$18B
| $8.5M | ﹤0.01% |
124,689
+33,548
| +37% | +$2.1M |
|
2164
Pembina Pipeline
PBA
$28.4B
| $8.49M | ﹤0.01% |
234,663
+76,028
| +48% | +$2.63M |
|
2165
Ameris Bancorp
ABCB
$5.9B
| $8.48M | ﹤0.01% |
176,022
+36,438
| +26% | +$1.76M |
|
2166
Five Below
FIVE
$13B
| $8.48M | ﹤0.01% |
127,872
+122,603
| +2,327% | +$7.36M |
|
2167
United Natural Foods
UNFI
$2.86B
| $8.47M | ﹤0.01% |
171,978
+18,476
| +12% | +$807K |
|
2168
Novavax
NVAX
$1.31B
| $8.46M | ﹤0.01% |
341,283
+31,366
| +10% | +$765K |
|
2169
Dell
DELL
$298B
| $8.43M | ﹤0.01% |
369,661
-3,225,871
| -90% | -$73.1M |
|
2170
CALL
American Tower
AMT
$79.3B
| $8.43M | ﹤0.01% |
59,100
+4,100
| +7% | +$585K |
|
|
LION
2171
DELISTED
Fidelity Southern Corporation
LION
| $8.43M | ﹤0.01% |
386,475
-13,683
| -3% | -$302K |
|
2172
Teledyne Technologies
TDY
$31.6B
| $8.41M | ﹤0.01% |
46,438
+30,613
| +193% | +$5.38M |
|
2173
Dorman Products
DORM
$3.92B
| $8.38M | ﹤0.01% |
137,117
+14,096
| +11% | +$956K |
|
|
MPT
2174
Medical Properties Trust
MPT
$2.41B
| $8.38M | ﹤0.01% |
607,854
-33,987
| -5% | -$459K |
|
|
FPRX
2175
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $8.37M | ﹤0.01% |
382,023
+96,660
| +34% | +$3.11M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.